Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 17, 2021
Total Value: $484M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MGNX | MACROGENICS INC | 1,350,000 | $43M | 8.9% | $17.94 | +35.4% | COM | 556099109 |
| RCKT | ROCKET PHARMACEUTICALS INC | 760,000 | $33.72M | 7.0% | $37.91 | +44.8% | COM | 77313F106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 930,000 | $29.44M | 6.1% | $18.95 | +118.7% | COM | 462260100 |
| — | SAGE THERAPEUTICS INC | 382,085 | $28.6M | 5.9% | $46.88 | — | COM | 78667J108 |
| — | INTERSECT ENT INC | 1,332,773 | $27.83M | 5.8% | $19.16 | — | COM | 46071F103 |
| EXEL | EXELIXIS INC | 1,201,100 | $27.13M | 5.6% | $21.93 | +3.0% | COM | 30161Q104 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 156,406 | $26.16M | 5.4% | $89.14 | +87.0% | COM | 91307C102 |
| — | ARENA PHARMACEUTICALS INC | 375,870 | $26.08M | 5.4% | $57.75 | — | COM NEW | 040047607 |
| PODD | INSULET CORP | 89,600 | $23.38M | 4.8% | $254.61 | +5.2% | COM | 45784P101 |
| — | MIRATI THERAPEUTICS INC | 135,000 | $23.13M | 4.8% | $171.30 | — | COM | 60468T105 |
| BIIB | BIOGEN INC | 75,000 | $20.98M | 4.3% | $269.69 | 0.0% | COM | 09062X103 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 861,410 | $20.41M | 4.2% | $21.69 | +9.5% | COM | 19459J104 |
| — | CONSTELLATION PHARMCETICLS I | 872,415 | $20.41M | 4.2% | $35.95 | — | COM | 210373106 |
| — | KADMON HLDGS INC | 4,755,000 | $18.5M | 3.8% | $4.16 | — | COM | 48283N106 |
| OCUL | OCULAR THERAPEUTIX INC | 1,007,012 | $16.52M | 3.4% | $15.51 | +24.2% | COM | 67576A100 |
| TVTX | TRAVERE THERAPEUTICS INC | 593,712 | $14.82M | 3.1% | $27.63 | 0.0% | COM | 89422G107 |
| LNTH | LANTHEUS HLDGS INC | 649,516 | $13.88M | 2.9% | $18.14 | 0.0% | COM | 516544103 |
| PBYI | PUMA BIOTECHNOLOGY INC | 1,300,000 | $12.64M | 2.6% | $10.19 | +9.6% | COM | 74587V107 |
| — | NEVRO CORP | 80,000 | $11.16M | 2.3% | $139.50 | — | COM | 64157F103 |
| IFRX | INFLARX NV | 2,200,000 | $8.58M | 1.8% | $5.12 | 0.0% | COM | N44821101 |
| ACAD | ACADIA PHARMACEUTICALS INC | 311,217 | $8.029M | 1.7% | $30.25 | +45.5% | COM | 004225108 |
| LUNG | PULMONX CORP | 114,345 | $5.23M | 1.1% | $52.64 | +9.0% | COM | 745848101 |
| — | REDHILL BIOPHARMA LTD | 705,305 | $5.163M | 1.1% | $7.32 | — | SPONSORED ADS | 757468103 |
| — | PROMETHEUS BIOSCIENCES INC | 250,000 | $4.565M | 0.9% | $18.26 | — | COM | 74349U108 |
| — | Y-MABS THERAPEUTICS INC | 150,000 | $4.536M | 0.9% | $30.24 | — | COM | 984241109 |
| GERN | GERON CORP | 2,610,000 | $4.124M | 0.9% | $1.49 | +19.5% | COM | 374163103 |
| — | AEGLEA BIOTHERAPEUTICS INC | 502,900 | $3.983M | 0.8% | $7.92 | — | COM | 00773J103 |
| — | TRICIDA INC | 349,600 | $1.849M | 0.4% | $5.29 | — | COM | 89610F101 |